Shivba Hospital Private Limited
Founded in 2015 and headquartered in Maharashtra, India.
2015 | Thane, Maharashtra (India) | Active
Shivba Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -974.13%
- Net Worth -134.87%
- Total Assets -77.46%
About Shivba Hospital
Shivba Hospital Private Limited (SHPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2015 (Nine years and nine months 3 days old ). Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Ars Pharmacare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samruddha Pradhan, Reshma Kesharwani, Rajkumari Jain, and One other member serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2015PTC264876
- Company No.
264876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Shivba Hospital?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samruddha Pradhan  | Director | 01-May-2021 | Current |
| Reshma Kesharwani | Director | 01-May-2021 | Current |
| Rajkumari Jain | Director | 01-May-2021 | Current |
| Asha Sharma | Director | 01-May-2021 | Current |
Financial Performance of Shivba Hospital.
Shivba Hospital Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 974.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 134.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shivba Hospital?
In 2017, Shivba Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shivba Hospital?
Unlock and access historical data on people associated with Shivba Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivba Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivba Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
